2026 Annual Meeting | C156 - History of Neurology

Date Tuesday 04/21/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alison L. Christy, MD, PhD, FAAN

Topic(s) History of Neurology

Learning Objectives Participants should become familiar with how medications are developed in neurology—not necessarily from bench to bedside, but from happy accidents and outside-the-box thinking—and consider how observations in the clinic can lead to novel developments in neurology.

CME Available 2.00 CME credits

Core Competencies Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
03:30 PM - 03:40 PM CDT	Introduction	Intro Alison L. Christy, MD, PhD, FAAN
03:40 PM - 04:00 PM CDT	Speaker	Serendipity in the Development of Epilepsy Medications Dorottya Kacsoh
04:00 PM - 04:20 PM CDT	Speaker	Vigabatrin and the Pediatric Epilepsy Research Foundation® Roy D. Elterman, MD, FAAN
04:20 PM - 04:40 PM CDT	Speaker	Serendipity in the Development of Medications for Parkinson's Disease Manon Auffret, PhD, PharmD, DAAN

Faculty Disclosures
Alison L. Christy, MD, PhD, FAAN	Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie.
Roy D. Elterman, MD, FAAN	Dr. Elterman has received intellectual property interests from a discovery or technology relating to health care. Dr. Elterman has a non-compensated relationship as a Co-Founder and Treasurer (previously president 2004-2024) with Pediatric Epilepsy Research Foundation® (PERF®) that is relevant to AAN interests or activities.
Manon Auffret, PhD, PharmD, DAAN	Dr. Auffret has received personal compensation for serving as an employee of France Développement Electronique. Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aguettant. The institution of Dr. Auffret has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aguettant. The institution of Dr. Auffret has received research support from Oxylis Medical. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care. Dr. Auffret has received publishing royalties from a publication relating to health care.
Dorottya Kacsoh	Dr. Kacsoh has nothing to disclose.

��ɫ��

��ɫ��